Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches

European Journal of Immunology

Volumn 31, Issue 4, 2001, Pages 1278-1287

  Spahn, Thomas W ^a,e   Fontana, Adriano ^b   Faria, Ana M C ^a   Slavin, Anthony J ^a   Eugster, Hans Pietro ^b   Zhang, Xingmin ^a   Koni, Pandelakis A ^c   Ruddle, Nancy H ^c   Flavell, Richard A ^c   Rennert, Paul D ^d   Weiner, Howard L ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BIOGEN   (United States)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Knockout; Lymph node; Suppression; Tolerance; Transgenic

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOTOXIN; OVALBUMIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FECES ANALYSIS; GENE MUTATION; GENE TARGETING; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOID ORGAN; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROGENY;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; GENE DELETION; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INTERFERON TYPE II; INTERLEUKIN-2; LYMPH NODES; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PEYER'S PATCHES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035063241     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A     Document Type: Article

References (46)

1. Biological reactions of the vegetable proteins. I. Anaphylaxis
2. Oral tolerance: Mechanisms and therapeutic applications
3. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
4. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
5. In situ immune response in gut associated lymphoid tissue (GALT) following oral antigen in TCR transgenic mice
6. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
7. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
8. Peripheral deletion of antigen-reactive T cells in oral tolerance
9. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines
10. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis
11. Induction of T cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells
12. A subset of gamma delta T cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization
13. Mediators of inflammation
14. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface
15. A lymphotoxin-β-specific receptor
16. Lymphotoxin-alpha-deficient mice: Effects on secondary lymphoid development and humoral immune responsiveness
17. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
18. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice
19. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor
20. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice
21. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: Genetic evidence of synergism with lymphotoxin beta
22. Surface lymphotoxin αβ complex is required for the development of peripheral lymphoid organs
23. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization
24. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function
25. The spleen and organized lymph nodes are not essential for the development of gut-induced mucosal immune responses in lymphotoxin-alpha deficient mice
26. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration
27. Simultaneous induction of antigen-specific IgA helper T cells and IgA suppressor T cells in the murine Peyer's patch after protein feeding
28. Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T cells in Peyer's patches of SJL mice
29. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
30. Induction of oral tolerance in rats without Peyer's patches
31. Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract
32. Graft-versus-host disease induces expression of la antigen in rat epidermal cells and gut epithelium
33. Demonstration of la antigens on mouse intestinal epithelial cells by immunoferritin labeling
34. HLA-DR-like antigens in the epithelium of the human small intestine
35. Evidence for function of la molecules on gut epithelial cells in man
36. Antigen presentation by epithelial cells of the rat small intestine. II Selective induction of suppressor T cells
37. + T cells
38. Expression of murine CD1 on gastrointestinal epithelium
39. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells
40. CD1d is involved in T cell-intestinal epithelial cell interactions
41. Characterization of tumor necrosis factor-deficient mice
42. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors
43. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
44. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients
45. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model
46. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin